Metabolic and Additional Vascular Effects of Thiazolidinediones
- 1 January 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 62 (10), 1463-1480
- https://doi.org/10.2165/00003495-200262100-00004
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- Effects of Tumor Necrosis Factor-α on Basal and Stimulated Endothelium-Dependent Vasomotion in Human Resistance VesselJournal of Cardiovascular Pharmacology, 2000
- Vascular reactivityThe American Journal of Cardiology, 1999
- Thiazolidinediones Down-Regulate Plasminogen Activator Inhibitor Type 1 Expression in Human Vascular Endothelial Cells: A Possible Role for PPARγ in Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- TroglitazoneDrugs, 1997
- Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect.JCI Insight, 1995
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- Effects of a New Oral Hypoglycaemic Agent (CS-045) on Metabolic Abnormalities and Insulin Resistance in Type 2 DiabetesDiabetic Medicine, 1994
- Effects of pioglitazone on calcium channels in vascular smooth muscle.Hypertension, 1994
- Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity.Hypertension, 1994
- Effects of ciglitazone on blood pressure and intracellular calcium metabolism.Hypertension, 1993